Mundipharma Submits New Analgesic Targin(R) (Prolonged Release Oxycodone / Naloxone Combination) For European Approval

Mundipharma announced that Targin®, an oral prolonged-release oxycodone / naloxone combination tablet, has been submitted for regulatory approval in Europe. Targin® is a combination of a strong opioid receptor agonist, oxycodone, and a locally acting opioid receptor antagonist, naloxone.

More: continued here

Filed under: GastroIntestinal / Gastroentorology on July 16th, 2008